Formulation: A solution in ethanol
Formal Name: N-((R)-2-hydroxypropyl)docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenamide
Purity: ≥98%
Formula Markup: C25H39NO2
Formula Weight: 385,6
Shelf life (days): 365
Notes: N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. Docosahexaenoyl ethanolamide (DHEA) has potential signaling roles in cancer, inflammation, and neurological development and functioning.{21496,19917,19740,13859} At least some of DHEA’s effects are mediated through cannabinoid (CB) receptors, while some NAEs also act as vanilloid receptor agonists and voltage-gated K+ channel blockers.{21496,13859,19780} (R)-(−)-Docosahexaenyl-2’-hydroxy-1’-propylamide is a homolog of DHEA, characterized by the addition of an (R)-β-methyl group at the terminal ethanolamine carbon. A similar modification of arachidonoyl ethanolamide (Item No. 90050) to produce R-2 methanandamide (Item No. 90074) imparts diminished affinity for the CB receptor as well as reduced metabolic stability.{1092} The physiological actions of this compound have not been evaluated.
English
Deutsch
